Completion of Tier 2 Reg. Cap. Facility Renewal
4 June 2024
Arbuthnot Banking Group PLC
Completion of Tier 2 Regulatory Capital Loan Facility Renewal
Further to the announcement on 19 December 2023, Arbuthnot Banking Group PLC ("ABG", the "Company" or the "Group") announces today that it has completed the renewal of the private issue of its sub-ordinated loan ("the Loan"), which is classified as Tier 2 for capital purposes, issued on a bilateral basis to P Capital Partners, a Swedish Debt fund.
As part of the renewal, the Loan was also increased by £1,000,000 to £26,000,000 before fees and expenses. The Loan is expected to mature on 3 June 2034 but can be repaid by ABG after the fifth anniversary. Interest is payable on the Loan at a rate of 7.25% plus SONIA.
The Directors of the Company accept responsibility for the contents of this announcement.
The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
Enquiries:
Arbuthnot Banking Group 020 7012 2400
Sir Henry Angest, Chairman and Chief Executive
Andrew Salmon, Group Chief Operating Officer
James Cobb, Group Finance Director
Grant Thornton UK LLP (Nominated Adviser and
AQSE Exchange Corporate Adviser) 020 7383 5100
Colin Aaronson
Samantha Harrison
Ciara Donnelly
Shore Capital (Broker) 020 7408 4090
Daniel Bush
David Coaten
Tom Knibbs
H/Advisors Maitland (Financial PR) 020 7379 5151
Sam Cartwright
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.